Quarterly Report • Sep 4, 2025
Quarterly Report
Open in ViewerOpens in native device viewer

The Group reports double order bookings, increased sales in all operating areas and a positive earnings trend in the first quarter of 2025/2026. In geographic terms, the US along with the Swedish operations made the largest contribution to the sales growth, despite the fact the outcomes in the US were hampered by exchange-rate effects. The ongoing transition to service sales is progressing well, with growing recurring revenue.
Figures in parentheses pertain to the corresponding period/quarter in the preceding fiscal year.
| Key figures | Quarter | 12 months | ||||
|---|---|---|---|---|---|---|
| SEK million | Q1 25/26 |
Q1 24/25 |
Δ % |
R12 25/26 |
Full-year 24/25 |
Δ % |
| Contracted order bookings | 1,309.5 | 615.0 | 112.9 | 9,400.6 | 8,706.1 | 8.0 |
| of which guaranteed order bookings | 1,192.3 | 543.1 | 119.5 | 8,302.2 | 7,653.0 | 8.5 |
| Net sales | 765.9 | 723.8 | 5.8 | 3,281.8 | 3,239.8 | 1.3 |
| of which recurring revenue | 549.2 | 482.3 | 13.9 | 2,134.2 | 2,067.4 | 3.2 |
| of which cloud recurring revenue (CRR) | 179.4 | 122.8 | 46.1 | 647.7 | 591.1 | 9.6 |
| Operating profit 2 | 118.8 | 99.8 | 19.0 | 742.0 | 723.0 | 2.6 |
| excluding patent settlement | 118.8 | 99.8 | 19.0 | 632.0 | 613.0 | 3.1 |
| Operating margin 2, % | 15.5 | 13.8 | n/a | 22.6 | 22.3 | n/a |
| excluding patent settlement, % | 15.5 | 13.8 | n/a | 19.3 | 18.9 | n/a |
| Profit for the period 2 | 102.8 | 80.4 | 27.9 | 585.8 | 563.4 | 4.0 |
| Churn, % | n/a | n/a | n/a | 0.7 | 0.6 | n/a |
| Earnings per share, SEK 1, 2 | 0.53 | 0.42 | 26.2 | 3.04 | 2.92 | 4.1 |
| Cash flow from operations | 118.1 | -56.7 | 308.3 | 1,097.2 | 922.4 | 19.0 |
| Average no. of employees | 1,328 | 1,222 | 8.7 | 1,275 | 1,249 | 2.1 |
1 Before and after dilution
2 The outcomes for the full year and R12 include a patent settlement that had a positive impact of SEK 110 million on operating profit. The business transaction was a nonrecurring item and was recognized in its entirety during the third quarter of 2024/2025.

Bars show the outcome per quarter and lines show the outcome for the rolling 12-month period (R12). Amounts are restated in SEK million unless otherwise indicated. Amounts in parentheses pertain to the corresponding quarter/period in the preceding fiscal year.
September 4, 2025 at 10:00 a.m. (CEST) Follow online: https://investor.sectra.com/q1report2526

The fiscal year started with a favorable performance in both medical IT and cybersecurity. Growth in North America was particularly notable. We are also making progress in our change of business model to selling medical diagnostic imaging to healthcare providers as a service. At the same time, we continue to strengthen society's resilience against cyberthreats through our information security solutions.
In our medical operations, our growth in the US and Canada is continuing at a rapid rate. During the quarter, we secured new contracts with some of the most reputable healthcare providers in the region, while also renewing and expanding contracts with existing customers. High customer satisfaction remains a strong competitive advantage that is contributing to our success and enabling us to create long-term relationships.

Torbjörn Kronander, President and CEO
During the quarter, we also received two new healthcare cybersecurity certifications—Texas Ramp in the US and C5 in Germany. The certifications were a result of our extensive work related to the security of healthcare IT solutions. It is crucial for hospitals that their systems are robust, as a breach could pose a risk for patients and lead to enormous costs for the hospitals themselves. These certifications are therefore important, and in some cases a requirement, for offering our services.
The extensive customer contracts we secured in the last fiscal year will soon enter a phase during which customers will start to deploy our solutions, albeit gradually over a number of years. While several large healthcare providers will start producing examinations in 2025/2026, we expect the financial impact from this to remain relatively small during the fiscal year. Once these customers go live, our focus will be on helping them to maximize the benefits of our services and increasing their use—efforts that will ultimately generate stable growth in recurring revenue and further strengthen our customer relationships.
In Secure Communications, we see continuing favorable demand, not least as a result of security developments. While NATO's decision during the summer to increase member states' defense and security investments has not had an immediate impact on our business, it will create further opportunities in the long term. We are well positioned to contribute solutions for secure communication and information sharing that make societies more resistant to cyberthreats. Our solutions were used, for example, at the NATO summit in the Netherlands during the summer (refer to page 10). This is a highly prestigious recognition and a clear indication that we have captured a leading position in our segment. This example demonstrates how our innovations help customers to protect decision-makers and citizens alike, at a time when information security is more important than ever. Our technologies, such as Tiger/S and other security solutions we develop, protect sensitive data and ensure that diplomacy and crisis management can occur under secure conditions.
Efficient medical care and cybersecurity are areas that will continue to grow for a long time to come. We grow by adding new customers, and by existing customers remaining with us and increasing their use of our services. Together with our customers, we are continuing to work for a healthier and safer society. Our comprehensive transformation to selling services that are delivered via the cloud is a strategic initiative to position us for the future. We are doing this to be able to deliver faster, become more scalable and create more secure solutions for our customers, who need to manage growing image volumes, ease the burden on their IT departments and strengthen their protection against cyberthreats. The initiative is laying the foundation for enterprise imaging, integrated diagnostics and precision medicine. However, the transition will require persistence and a long-term focus. Although it will have a negative impact on our financial performance in the short term, it will provide us with a stronger and more scalable business model in the long term. Thanks to this transformation, a high level of customer trust, and innovative offerings, we are well equipped for the future.

Cloud services +46%
recurring revenue y-o-y
Churn
0.7% of recurring revenue
R12

Sectra's overall operational target is to create significant customer value. Customers should be so satisfied with their experience that they remain for a long time, expand their use of our solutions and recommend Sectra to others. Delivering customer value is also the Group's most important sustainability target since our customers' work to treat patients and increase cybersecurity is essential for functioning societies.
Customer satisfaction requires satisfied and dedicated employees. Employees who are motivated, understand their customers and feel a sense of well-being will also increasingly develop new, creative solutions that can further increase the value we provide for Sectra's customers. Operating in markets that are growing, combined with satisfied customers and employees, provides a longterm sound financial performance.
Sectra has three Group-wide financial goals. Stability and profitability are considered fundamental goals. Once these goals have been met, the focus shifts to earnings growth per share, which in practice is our primary financial goal. All result indicators currently exceed the target levels by a comfortable margin despite the effects of changes in the business model. The financial goals are (in order of priority):
0
Q1
Q2
Q3
Q4
Q1
Q2
23/24 24/25 25/26
Q3
Q4
Q1
25
50
75
100
%
The equity/assets ratio exceeded the target due to a strong financial position.
1 The line in the diagram shows the outcomes at the end of the periods including the patent settlement in the third quarter of 2024/2025. The patent settlement did not have any material effect on the outcome.

The operating margin was impacted by the ongoing transformation of the business model, with a large share of growth attributable to entirely new customers. This entails an initial increase in costs before these customers reach the expected volumes. Including the patent settlement, the operating margin for the latest rolling 12-month period was 22.6%.
The profit growth is well above the goal. Operating profit per share has grown as a result of higher revenue and cost control, which explains the increase in the first quarter of 2025/2026. Including the patent settlement, growth was 152.7% over the last five years.


0
Q1
Q2
Q3
Q4
Q1
Q2
23/24 24/25 25/26
Outcome of operational targets
Q3
Q4
Q1
10
20
30
40
%

High level of customer satisfaction High level of quality and product safety
Dedicated employees who are satisfied, feel a sense of well-being, are developing as individuals, and do their best to meet or exceed customer expectations

No events of significant importance for the assessment of Sectra's financial position and earnings took place between the balance-sheet date and the publication date of this interim report.

A private healthcare provider delivering medical imaging services at more than 20 hospitals and clinics in the UK went live with Sectra One Cloud during the first quarter. With our services and our scalable enterprise imaging solution operated in a public cloud, we are helping the customer modernize and streamline the management of nearly 500,000 exams per year within radiology and mammography. The first sites went live in mid-June 2025, and within two weeks all sites were using Sectra's services. The healthcare provider's organization has previously deployed Sectra's solutions at some of its clinics in the US.
Sectra plays a key role in meeting the need for medical imaging IT and cybersecurity. We help solve major social problems in changing markets, where scope for expansion remains. The global trends of an aging population and increased digitization mean that these markets are expected to continue to grow regardless of the economic climate. Information about the company's markets can be found in Sectra's latest Annual Report and Sustainability Report.
Contracted order bookings for the quarter rose 112.9% to SEK 1,309.5 million (615.0). The year-on-year increase was primarily attributable to the operations in the US and Canada. A total of SEK 1,192.3 million (543.1) was guaranteed order bookings. The ratio of contracted order bookings to net sales for the latest rolling 12-month period totaled 2.9, compared with 2.7 at the end of the previous fiscal year.
Order bookings often include comprehensive, long-term customer contracts. These are not signed every quarter and can lead to significant variations in order bookings between individual quarters and periods.
The Group's net sales rose 5.8% to SEK 765.9 million (723.8). Based on unadjusted exchange rates, consolidated sales increased 12.1% year-on-year.
The ongoing transition to selling products and software as services, of which cloud deliveries account for a quickly growing share, contributed to an increase in recurring revenue. Recurring revenue accounted for SEK 549.2 million (482.3) of sales. This represents an increase of 13.9% and an increase of 20.8% based on unadjusted exchange rates. Lost recurring revenue (recurring revenue churn) for the last 12-month period was 0.7%. Cloud recurring revenue (CRR) increased 46.1% to SEK 179.4 million (122.8). Non-recurring revenue decreased 10.3% to SEK 216.7 million (241.5) due to the ongoing transition to service deliveries.
All operating areas contributed to the Group's sales growth. In geographic terms, the operations in the US and Sweden reported the single largest year-on-year sales increases. More than 70% of the Group's sales are carried out in foreign currency, primarily EUR, GBP and USD, which entails a relatively large sensitivity to currency fluctuations.

Sales trend per operating area, SEK million
Compared with the corresponding period of the preceding fiscal year

Sales trend per geographic market, SEK million Compared with the corresponding period of the preceding fiscal year


Revenue (per quarter) and sales (R12), SEK million Sales (R12) by geographic market, SEK million
Operating profit trend per operating area, SEK million

The Group's operating profit increased 19.0% to SEK 118.8 million (99.8). Based on unadjusted exchange rates, the year-on-year increase was 35.9%. All operating areas reported higher operating profit than in the comparative quarter. The Group's operating margin amounted to 15.5% (13.8). The outcome includes SEK 36.1 million (12.5) in costs for share-based incentive programs. The increase was partly attributable to the start of a new program after the comparative quarter and partly to the share price trend.
The Group's financial items amounted to SEK 11.5 million (1.4). Currency fluctuations had an impact of SEK 5.3 million (-1.7) on the Group's financial items. Sectra does not hedge its operations, and currency fluctuations therefore have an immediate impact on profit or loss or on comprehensive income.
Profit after financial items amounted to SEK 130.3 million (101.3). This outcome corresponds to a profit margin of 17.0% (14.0). Earnings per share before and after dilution totaled SEK 0.53 (0.42).

Operating profit for the Group, SEK million
Q4
Q1

The Group's cash and cash equivalents at the end of the reporting period amounted to SEK 1,426.5 million (699.4).
The Group's debt/equity ratio was 0.05 (0.03) as of the balance-sheet date. Interest-bearing lease liabilities amounted to SEK 96.7 million (45.9). The change was due to the fact that several new leases were signed during the preceding fiscal year as a result of Sectra's growth.
Cash flow from operations amounted to SEK 118.1 million (-56.7). The change was primarily the result of a decrease in capital tied up in current receivables.
Cash flow per share amounted to SEK 0.61 (-0.29).
Cash flow from investing activities amounted to SEK -31.2 million (-43.1). Refer to the additional information about investments below.
The Group's total cash flow for the period amounted to SEK 80.6 million (-104.1).
Investments amounted to SEK 31.2 million (43.1). Capitalized work for own use amounted to SEK 23.0 million (12.9). Capitalization includes the development of cloud-based services for medical diagnostics.
Total depreciation/amortization amounted to SEK 27.6 million (26.1). Of the total depreciation/amortization for the quarter, SEK 12.7 million (11.0) was attributable to capitalized development expenditures. At the end of the period, capitalized development expenditures totaled SEK 243.0 million (204.7).
Sectra has historically experienced major seasonal variations, since individual projects can be very large relative to Sectra's sales. This applies for both medical systems and encryption systems. The beginning of the fiscal year is usually weaker since few customers want to deploy new systems during the summer. The variations in order volumes between individual quarters are significant since certain contracts are very large and have long terms.
As Sectra transitions to selling products as a service, this variation is expected to gradually decrease over the next several years since revenue will be spread more evenly over time. On the other hand, individual orders are sometimes very large, leading instead to a larger variation in order bookings than before.
Bearing this in mind, it remains important to look more at long-term trends rather than at the outcome for an individual quarter when assessing Sectra's performance.
Cash flow from operations for the Group, SEK million

Capitalized development expenditures, SEK million

Carrying amount at end of period
Read Sectra's 2024/2025 Annual Report and Sustainability Report
https://investor.sectra.com/annual-reports


| Quarter | 12 months | ||||||
|---|---|---|---|---|---|---|---|
| Q1 | Q1 | Δ | R12 | Full-year | Δ | ||
| 25/26 | 24/25 | % | 25/26 | 24/25 | % | ||
| Sales, SEK million | 665.0 | 639.9 | 3.9 | 2,823.1 | 2,798.0 | 0.9 | |
| of which external recurring revenue | 513.3 | 448.9 | 14.3 | 1,989.2 | 1,924.8 | 3.3 | |
| of which cloud recurring revenue | 174.7 | 117.6 | 48.6 | 628.6 | 571.5 | 10.0 | |
| Operating profit, SEK million | 113.7 | 95.0 | 19.7 | 586.3 | 567.6 | 3.3 | |
| Operating margin, % | 17.1 | 14.8 | n/a | 20.8 | 20.3 | n/a |
Imaging IT Solutions noted sales growth and a year-on-year increase in operating profit. Recurring revenue grew, primarily due to customers' increased use of Sectra's cloud-based services for medical imaging. Nonrecurring revenue was lower than in the comparative quarter, mainly as a result of customers purchasing services instead of traditional software licenses.
Profitability was impacted by ongoing initiatives, the most extensive of which was the transition to becoming a service provider. Currency also had a negative impact on outcomes. While these factors had dampening effects on the financial outcome, they have thus far been offset by the strong underlying growth of the operations.
Numerous new customers will go live during the fiscal year and in the coming years. Work to prepare for the deliveries is ongoing, and none of the largest customers are in full production yet. Revenue is growing as customers put the systems into operation, but it could take several years for major customers to become fully operational and reach planned volumes. One of those new, major customers is MSSS Québec in Canada. The client has been dealing with a legal challenge regarding the award of the contract. The challenge has now been closed and no longer poses a risk to the project.
During the first quarter, Sectra signed additional contracts with prestigious customers, mainly in the US and Canada but also in other parts of the world. Order bookings include agreements with new customers, add-on orders and contracts with existing customers who have chosen to convert from Sectra's traditional system solutions to Sectra One.




| Quarter | 12 months | |||||
|---|---|---|---|---|---|---|
| Q1 | Q1 | Δ | R12 | Full-year | Δ | |
| 25/26 | 24/25 | % | 25/26 | 24/25 | % | |
| Sales, SEK million | 22.2 | 17.6 | 26.1 | 95.4 | 90.8 | 5.1 |
| of which external recurring revenue | 5.4 | 5.8 | -6.9 | 22.8 | 23.2 | -1.7 |
| of which cloud recurring revenue | 4.7 | 5.2 | -9.6 | 19.1 | 19.5 | -2.1 |
| Operating profit/loss, SEK million | 1.6 | -0.3 | 633.3 | 11.8 | 9.9 | 19.2 |
| Operating margin, % | 7.2 | neg | n/a | 12.4 | 10.9 | n/a |
Business Innovation comprises the Genomics IT, Medical Education and Orthopaedics business units. We also report the expenses for medical research activities in Business Innovation, which includes initiatives in the field of AI for medical applications. Sectra's research activities linked to secure communications are organized and reported in the Secure Communications operating area.
While the segment's recurring revenue was lower than in the comparative quarter, this was offset by higher non-recurring revenue in both the Medical Education and the Orthopaedics units. However, the results may vary significantly between quarters and periods. In the long term, subscriptionbased business models and growing volumes are expected to reduce quarterly variations.
Trend, SEK million

Genetic information is increasingly being used, particularly in cancer care. Managing the dramatic increase in genomics data for medical diagnostics poses a major challenge. New methods are therefore needed to provide patients with better and more customized diagnostics and treatment. As part of a doctoral project, Emilia Ståhlbom is developing new types of visualization concepts that bring together different types of data. Emilia is an industrial PhD student at the Department of Media and Information Technology at Linköping University and a Sectra employee.
"We are trying to combine as much information as possible in a single visualization. This provides a faster overview of large volumes of data and makes it possible to more efficiently find relevant information and more mutations that may be important to the patient's treatment," says Emilia Ståhlbom.
The vision for the research project is to create a detailed picture of the patient's disease and handle even larger amounts of data, making DNA sequencing a routine part of healthcare and allowing more patients to receive more personalized care.


| Quarter | 12 months | |||||
|---|---|---|---|---|---|---|
| Δ Q1 Q1 |
R12 | Full-year | Δ | |||
| 25/26 | 24/25 | % | 25/26 | 24/25 | % | |
| Sales, SEK million | 92.8 | 77.5 | 19.7 | 422.2 | 407.0 | 3.7 |
| of which external recurring revenue | 30.5 | 27.3 | 11.7 | 122.0 | 118.7 | 2.8 |
| Operating profit 1, SEK million | 10.8 | 10.1 | 6.9 | 174.9 | 174.2 | 0.4 |
| excl. patent settlement, SEK million | 10.8 | 10.1 | 6.9 | 64.9 | 64.2 | 1.1 |
| Operating margin 1, % | 11.6 | 13.0 | n/a | 41.4 | 42.8 | n/a |
| excl. patent settlement, % | 11.6 | 13.0 | n/a | 15.4 | 15.8 | n/a |
1 The outcomes for the full year and R12 include a patent settlement that had a positive impact of SEK 110 million on operating profit. The business transaction was a nonrecurring item and was recognized in its entirety during the third quarter of 2024/2025.
Secure Communications noted sales growth and increased operating profit. This growth was driven by Sectra's ability to help customers protect their communications and critical infrastructure, which has led to growing volumes of product deliveries and development assignments. The outcome varies considerably between quarters, which is natural given the nature of the operations.
The financial development was temporarily hampered by the fact that an ongoing development assignment in a major customer project was extended at the end of the previous fiscal year. While it is positive that the project was extended, this also means that the contracted serial deliveries that should have started at the end of the last fiscal year have been postponed until the end of 2025/2026.
The unstable global security situation is continuing to fuel the need for investments in high assurance products, encryption development and cybersecurity. Sectra is well positioned to respond to the needs of the market, with offerings that meet customers' stringent demands. During the first quarter, some customers extended their existing contracts to ensure access to Sectra's products and services for secure communications as well as security monitoring of critical infrastructure.


During the quarter, Sectra's NATO-approved communication solution played a key role when the leaders of the NATO countries gathered in The Hague to discuss the serious security situation and the need for increased defense investment.
The Dutch authorities in charge of hosting chose to use Sectra's services for secure communication before and during the summit. Sectra's NATOapproved encryption solutions enabled efficient and secure collaboration between authorities, including ministries, security services and the police. The assignment highlights how Sectra's innovations are used to strengthen international security and protect sensitive information.

| Quarter | 12 months | ||||||
|---|---|---|---|---|---|---|---|
| Q1 | Q1 | Δ | R12 | Full-year | Δ | ||
| 25/26 | 24/25 | % | 25/26 | 24/25 | % | ||
| Sales, SEK million | 67.9 | 47.3 | 43.6 | 237.5 | 216.9 | 9.5 | |
| Operating loss, SEK million | -9.1 | -9.1 | 0.0 | -37.2 | -37.2 | 0.0 | |
| Operating margin, % | neg | neg | n/a | neg | neg | n/a |
Other Operations pertain to Sectra's joint functions for administration, recruitment, Group finance, IT, regulatory affairs, people and brand, and activities related to investors. This segment also includes property management. The change from the comparative period mainly pertained to increased central management of costs distributed across the organization.
The Parent Company's income statement and balance sheet are reported on page 16. The Parent Company Sectra AB includes the research department for medical imaging IT, the Genomics IT business unit and the head office's joint functions (see Other Operations above).
The AGM will be held on September 9, 2025 in Linköping. Visit the event page https://investor.sectra.com/agm2025 for information on the proposals of the Board and the Nomination Committee as well as the documentation for the AGM.
For the 2024/2025 fiscal year, the Board and CEO have proposed that the AGM resolve on an ordinary dividend of SEK 1.10 per share and an extraordinary dividend of SEK 1.00 per share, considering the year's strong cash flow and Sectra's financial position. The proposed record date for receiving dividends is September 11, 2025. If the AGM resolves in accordance with the Board's proposal, payment is expected to take place on September 16, 2025. The corresponding distribution to the shareholders in the preceding year was SEK 1.10 per share and was issued through a redemption program, a method that can no longer be used. The proposal was announced in Sectra's year-end report published on June 5, 2025.
Sectra's share capital on the balance-sheet date totaled SEK 39,024,179, distributed between 195,120,895 shares and 313,052,035 votes. The number of shares is distributed between 13,103,460 Class A shares and 182,017,435 Class B shares. Sectra's holding of treasury shares at the end of the period amounted to 2,453,406 Class B shares, corresponding to 1.3% of the share capital and 0.8% of the voting rights in the company. For more information, refer to Note 3.
The Board of Directors was authorized by the 2024 AGM, during the period until the 2025 AGM, to decide on new share issues of a maximum of 18,500,000 Class B shares and to decide on the acquisition and divestment of the company's treasury shares, with the condition that the Company's holding of treasury shares at no point exceeds 10% of all the shares in the Company. The complete authorization is presented in the minutes from the AGM: https://investor.com/agm2024. At the time of publication of this financial report, the Board had not utilized these authorizations.
Through its operations, Sectra is exposed to such business risks as dependence on major customers and partners, the effect of currency fluctuations on pricing in the markets in which the Group is active, and property and liability risks. Sectra is also exposed to various types of financial risks such as currency, interest-rate, credit and liquidity risks. A detailed description of the risks and specific external factors as well as Sectra's strategies and tactics for minimizing risk exposure and limiting adverse effects are provided in the Administration Report in Sectra's Annual and Sustainability Report for the 2024/2025 fiscal year on pages 68–91 and in Note 30 on pages 119–120. No significant events have occurred that would alter the conditions reported.

Contact Sectra's CEO Torbjörn Kronander, telephone +46 13 23 52 27 or email [email protected].
Time: September 4, 2025 at 10:00 a.m. (CEST)
Torbjörn Kronander, President and CEO of Sectra AB, and Jessica Holmquist, CFO of Sectra AB, will present the financial report and answer questions. The presentation will be held in English. For information about participating online or to listen to the recording afterwards, visit: https://investor.sectra.com/q1report2526.
| Annual General Meeting | September 9, 2025 at 3:30 p.m. (CEST) |
|---|---|
| Six-month interim report | December 12, 2025 at 8:15 a.m. (CET) |
| Nine-month interim report March 6, 2026 at 8:15 a.m. (CET) | |
| Year-end report | June 5, 2026 at 8:15 a.m. (CEST) |
For further information about IR events, visit https://investor.sectra.com/events-and-presentations/
The Board of Directors and the President of Sectra AB (publ) hereby assure that the interim report from May 1 to July 31, 2025 provides a true and fair view of the Parent Company's and Group's operations, financial position and earnings and describes the significant risks and uncertainties facing the Parent Company and other companies in the Group.
Linköping, date as indicated by our electronic signature
| Torbjörn Kronander | Jan-Olof Brüer | Tomas Puusepp |
|---|---|---|
| President, CEO and Board member | Chairman | Board member |
| Ulrika Unell | Anders Persson | Fredrik Robertsson |
| Board member | Board member | Board member |
| Birgitta Hagenfeldt | Pontus Svärd | Andreas Häll |
| Board member representative |
Board member and employee representative Board member and employee |
This report was not reviewed by the company's auditor.
This information constitutes information that Sectra AB (publ) is obligated to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of Sectra's contact person set out below, at 8:15 a.m. (CEST) on September 4, 2025.
Sectra AB (publ), Corporate Registration Number 556064-8304, https://sectra.com, email [email protected]

| SEK thousand | 3 months | 3 months | 12 months | Full-year |
|---|---|---|---|---|
| May–Jul | May–Jul | Aug 2024 | May–Apr | |
| 2025 | 2024 | –Jul 2025 | 2024/2025 | |
| Net sales (Note 4) | 765,854 | 723,836 | 3,281,829 | 3,239,811 |
| Capitalized work for own use | 23,007 | 12,915 | 84,185 | 74,093 |
| Other operating income 1 | 7,123 | 2,729 | 230,750 | 226,356 |
| Total income | 795,984 | 739,480 | 3,596,764 | 3,540,260 |
| Goods for resale | -105,193 | -103,285 | -443,620 | -441,712 |
| Personnel costs | -420,309 | -380,144 | -1,638,862 | -1,598,697 |
| Other external costs | -124,110 | -130,088 | -659,346 | -665,324 |
| Depreciation/amortization and | ||||
| impairment | -27,573 | -26,148 | -112,955 | -111,530 |
| Total operating expenses | -677,185 | -639,665 | -2,854,783 | -2,817,263 |
| Operating profit | 118,799 | 99,815 | 741,981 | 722,997 |
| Total financial items | 11,500 | 1,445 | 13,339 | 3,284 |
| Profit after financial items | 130,300 | 101,260 | 755,320 | 726,281 |
| Taxes | -27,515 | -20,859 | -169,566 | -162,910 |
| Profit for the period | 102,785 | 80,401 | 585,784 | 563,371 |
| Profit for the period attributable to: | ||||
| Parent Company owners | 102,785 | 80,401 | 585,754 | 563,371 |
| Earnings per share | ||||
| Before dilution, SEK | 0.53 | 0.42 | 3.04 | 2.92 |
| After dilution, SEK (Note 3) | 0.53 | 0.42 | 3.04 | 2.92 |
1 The outcome for full-year 2024/2025 include the patent settlement of SEK 195 million.
| SEK thousand | 3 months | 3 months | 12 months | Full-year |
|---|---|---|---|---|
| May–Jul | May–Jul | Aug 2024 | May–Apr | |
| 2025 | 2024 | –Jul 2025 | 2024/2025 | |
| Profit for the period | 102,785 | 80,401 | 585,754 | 563,371 |
| Items that may be reversed in profit or loss |
||||
| Translation differences | 9,086 | -3,450 | -34,991 | -47,527 |
| Total other comprehensive income for the period |
9,086 | -3,450 | -34,991 | -47,527 |
| Total comprehensive income for the | 111,871 | 76,951 | 550,763 | 515,844 |
| period | ||||
| Comprehensive income for the period | ||||
| attributable to: | ||||
| Parent Company owners | 111,871 | 76,951 | 550,763 | 515,844 |

| SEK thousand | Jul 31, 2025 |
Jul 31, 2024 |
Apr 30, 2025 |
|---|---|---|---|
| Assets | |||
| Intangible assets and goodwill | 295,323 | 263,633 | 283,063 |
| Tangible assets | 219,252 | 228,015 | 220,654 |
| Right-of-use assets | 115,320 | 68,539 | 106,415 |
| Financial assets | 245,453 | 165,157 | 178,464 |
| Deferred tax assets | 9,235 | 8,630 | 8,502 |
| Total fixed assets | 884,583 | 733,974 | 797,098 |
| Accounts receivable | 419,717 | 566,537 | 572,036 |
| Other current assets | 110,686 | 43,769 | 106,492 |
| Prepaid expenses and accrued income | 916,414 | 1,128,297 | 938,732 |
| Cash and bank balances | 1,426,469 | 699,355 | 1,341,871 |
| Total current assets | 2,873,286 | 2,437,958 | 2,959,131 |
| Total assets | 3,757,869 | 3,171,932 | 3,756,229 |
| Equity and liabilities | |||
| Equity | 2,046,764 | 1,654,220 | 1,916,825 |
| Deferred tax liabilities | 4,397 | 6,721 | 4,063 |
| Provisions | 84,377 | 33,729 | 58,318 |
| Non-current lease liabilities | 72,445 | 32,812 | 63,840 |
| Other long-term liabilities | 12,178 | – | 11,733 |
| Total long-term liabilities | 173,397 | 73,262 | 137,954 |
| Provisions | 6,653 | 3,364 | 5,619 |
| Current lease liabilities | 24,301 | 13,072 | 23,617 |
| Other current liabilities | 216,081 | 164,303 | 263,267 |
| Accrued expenses and deferred income | 1,290,673 | 1,263,711 | 1,408,947 |
| Total current liabilities | 1,537,708 | 1,444,450 | 1,701,450 |
| Total equity and liabilities | 3,757,869 | 3,171,932 | 3,756,229 |

| SEK thousand | 3 months May–Jul |
3 months May–Jul |
Full-year May–Apr |
|---|---|---|---|
| 2025 | 2024 | 2024/2025 | |
| Operating activities | |||
| Operating profit | 118,799 | 99,815 | 722,997 |
| Adjustment for non-cash items | 74,309 | 47,491 | 179,581 |
| Interest received | 7,562 | 3,731 | 31,403 |
| Interest paid | -1,340 | -561 | -4,308 |
| Income tax paid | -60,250 | -70,199 | -171,703 |
| Cash flow from operations before changes in working capital | 139,080 | 80,277 | 757,970 |
| Changes in working capital | |||
| Change in inventories | -6,683 | -11,412 | -1,108 |
| Change in receivables | 139,547 | -28,435 | -16,367 |
| Change in current liabilities | -153,806 | -97,146 | 181,869 |
| Cash flow from operations | 118,138 | -56,716 | 922,364 |
| Investing activities | |||
| Acquisitions of intangible assets | -24,482 | -12,914 | -75,237 |
| Acquisitions of tangible assets | -6,746 | -30,169 | -34,755 |
| Acquisition of financial assets | – | – | -3,872 |
| Cash flow from investing activities | -31,228 | -43,083 | -113,864 |
| Financing activities | |||
| Repayment of lease liabilities | -6,292 | -4,336 | -39,950 |
| Redemption of shares | – | – | -211,935 |
| Cash flow from financing activities | -6,292 | -4,336 | -251,885 |
| Cash flow for the period | 80,618 | -104,135 | 556,615 |
| Cash and cash equivalents, opening balance | 1,341,871 | 804,640 | 804,640 |
| Exchange-rate difference in cash and cash equivalents | 3,980 | -1,150 | -19,384 |
| Cash and cash equivalents, closing balance | 1,426,469 | 699,355 | 1,341,871 |
| SEK thousand | 3 months May–Jul |
3 months May–Jul |
Full-year May–Apr |
|---|---|---|---|
| 2025 | 2024 | 2024/2025 | |
| Equity at start of period | 1,916,825 | 1,569,591 | 1,569,591 |
| Comprehensive income for the period | 111,871 | 76,951 | 515,844 |
| Dividend/redemption of shares | – | – | -211,935 |
| Share-based payments | 18,068 | 7,678 | 43,325 |
| Equity at end of period | 2,046,764 | 1,654,220 | 1,916,825 |

| SEK thousand | 3 months | 3 months | 12 months | Full-year |
|---|---|---|---|---|
| May–Jul | May–Jul | Aug 2024 | May–Apr | |
| 2025 | 2024 | –Jul 2025 | 2024/2025 | |
| Net sales | 69,089 | 47,356 | 244,915 | 223,182 |
| Capitalized work for own use | 0 | 1,221 | 1,596 | 2,817 |
| Other operating income | 2,456 | 17 | 9,244 | 6,805 |
| Total income | 71,545 | 48,594 | 255,755 | 232,804 |
| Goods for resale | -22,814 | -10,577 | -67,854 | -55,617 |
| Personnel costs | -20,284 | -17,595 | -85,972 | -83,283 |
| Other external costs | -40,166 | -31,986 | -150,466 | -142,286 |
| Depreciation/amortization | -1,057 | -446 | -2,426 | -1,815 |
| Total operating expenses | -84,321 | -60,604 | -306,718 | -283,001 |
| Operating loss | -12,776 | -12,010 | -50,963 | -50,197 |
| Total financial items | 6,542 | 1,471 | 101,050 | 95,979 |
| Profit/loss after financial items | -6,234 | -10,539 | 50,087 | 45,782 |
| Appropriations | – | – | 542,000 | 542,000 |
| Profit/loss before tax | -6,234 | -10,539 | 592,087 | 587,782 |
| Tax on earnings for the period | – | – | -104,356 | -104,356 |
| Profit/loss for the period | -6,234 | -10,539 | 487,731 | 483,427 |
| SEK thousand | 3 months May–Jul 2025 |
3 months May–Jul 2024 |
12 months Aug 2024 –Jul 2025 |
Full-year May–Apr 2024/2025 |
|---|---|---|---|---|
| Profit/loss for the period | -6,234 | -10,539 | 487,731 | 483,427 |
| Total comprehensive income for the | ||||
| period | -6,234 | -10,539 | 487,731 | 483,427 |
| SEK thousand | Jul 31, | Jul 31, | Apr 30, |
|---|---|---|---|
| 2025 | 2024 | 2025 | |
| Assets | |||
| Intangible assets | 11,400 | 10,405 | 12,000 |
| Tangible assets | 6,799 | 7,240 | 6,975 |
| Financial assets | 322,357 | 375,074 | 330,409 |
| Total fixed assets | 340,556 | 392,719 | 349,384 |
| Accounts receivable | 2,997 | 945 | 9,190 |
| Receivables from Group companies | 704,511 | 856,651 | 1,113,990 |
| Other current assets | 38,403 | 23,647 | 41,474 |
| Cash and bank balances | 1,239,853 | 569,805 | 1,145,466 |
| Total current assets | 1,985,764 | 1,451,048 | 2,310,120 |
| Total assets | 2,326,320 | 1,843,767 | 2,659,504 |
| Equity and liabilities | |||
| Restricted equity | 276,880 | 275,684 | 277,480 |
| Unrestricted equity | 1,105,380 | 777,416 | 1,093,723 |
| Total equity | 1,382,260 | 1,053,100 | 1,371,203 |
| Provisions | 7,128 | 3,069 | 6,327 |
| Current liabilities | 936,932 | 787,598 | 1,281,974 |
| Total equity and liabilities | 2,326,320 | 1,843,767 | 2,659,504 |

This interim report has been prepared in accordance with IAS 34 Interim Financial Reporting, the Swedish Annual Accounts Act and the Swedish Securities Markets Act. The accounting policies and calculation methods applied are consistent with those described in Sectra's 2024/2025 Annual and Sustainability Report.
Other than the types of transactions presented in Note 3 Employees and personnel costs in the 2024/2025 Annual Report, no significant transactions with related parties took place in the reporting period.
| No. of common shares 1, 2 | 3 months May–Jul 2025 |
3 months May–Jul 2024 |
12 months Aug 2024 –Jul 2025 |
Full-year May–Apr 2024/2025 |
|---|---|---|---|---|
| At the end of the period | 192,667,489 | 192,667,489 | 192,667,489 | 192,667,489 |
| Average | 192,667,489 | 192,667,489 | 192,667,489 | 192,667,489 |
1 Before and after dilution.
2 Number of shares does not include the 2,453,406 (1,453,406) Class B treasury shares.
| SEK million | 3 months | 3 months | 12 months | Full-year |
|---|---|---|---|---|
| May–Jul | May–Jul | Aug 2024 | May–Apr | |
| 2025 | 2024 | –Jul 2025 | 2024/2025 | |
| Imaging IT Solutions | 665.0 | 639.9 | 2,823.1 | 2,798.0 |
| Secure Communications | 92.8 | 77.5 | 422.2 | 407.0 |
| Business Innovation | 22.2 | 17.6 | 95.4 | 90.8 |
| Other Operations | 67.9 | 47.3 | 237.5 | 216.9 |
| Group eliminations | -82.0 | -58.5 | -296.4 | -272.9 |
| Total | 765.9 | 723.8 | 3,281.8 | 3,239.8 |
| SEK million | 3 months | 3 months | 12 months | Full-year |
|---|---|---|---|---|
| May–Jul | May–Jul | Aug 2024 | May–Apr | |
| 2025 | 2024 | –Jul 2025 | 2024/2025 | |
| Imaging IT Solutions | 113.7 | 95.0 | 586.3 | 567.6 |
| Secure Communications | 10.8 | 10.1 | 174.9 | 174.2 |
| Business Innovation | 1.6 | -0.3 | 11.8 | 9.9 |
| Other Operations | -9.1 | -9.1 | -37.2 | -37.2 |
| Group eliminations | 1.8 | 4.1 | 6.2 | 8.5 |
| Total | 118.8 | 99.8 | 742.0 | 723.0 |
| 3 months | 3 months | 12 months | Full-year |
|---|---|---|---|
| May–Jul | May–Jul | Aug 2024 | May–Apr |
| 2025 | 2024 | –Jul 2025 | 2024/2025 |
| 210.4 | 179.0 | 930.9 | 899.5 |
| 152.0 | 132.9 | 647.0 | 627.9 |
| 155.1 | 156.7 | 611.9 | 613.5 |
| 186.2 | 187.2 | 826.8 | 827.8 |
| 62.2 | 68.0 | 265.2 | 271.1 |
| 765.9 | 723.8 | 3,281.8 | 3,239.8 |

| Group | ||||
|---|---|---|---|---|
| SEK million | 3 months | 3 months | 12 months | Full-year |
| May–Jul | May–Jul | Aug 2024 | May–Apr | |
| 2025 | 2024 | –Jul 2025 | 2024/2025 | |
| Recurring revenue | 549.2 | 482.3 | 2,134.2 | 2,067.4 |
| Of which cloud recurring revenue, CRR | 179.4 | 122.8 | 647.7 | 591.1 |
| Non-recurring revenue | 216.7 | 241.5 | 1,147.6 | 1,172.4 |
| Total | 765.9 | 723.8 | 3,281.8 | 3,239.8 |
| Share of recurring revenue, % | 71.7 | 66.6 | 65.0 | 63.8 |
| Imaging IT Solutions | ||||
| 3 months | 3 months | 12 months | Full-year | |
| SEK million | May–Jul | May–Jul | Aug 2024 | May–Apr |
| 2025 | 2024 | –Jul 2025 | 2024/2025 | |
| Recurring revenue | 513.3 | 448.9 | 1,989.2 | 1,924.8 |
| Of which cloud recurring revenue, CRR | 174.7 | 117.6 | 628.6 | 571.5 |
| Non-recurring revenue | 151.9 | 190.1 | 829.7 | 867.9 |
| Total | 665.2 | 639.0 | 2,818.9 | 2,792.7 |
| Share of recurring revenue, % | 77.2 | 70.3 | 70.6 | 68.9 |
| Secure Communications | ||||
| SEK million | 3 months | 3 months | 12 months | Full-year |
| May–Jul | May–Jul | Aug 2024 | May–Apr | |
| 2025 | 2024 | –Jul 2025 | 2024/2025 | |
| Recurring revenue | 30.5 | 27.3 | 122.0 | 118.7 |
| Of which cloud recurring revenue, CRR | – | – | – | – |
| Non-recurring revenue | 62.3 | 50.1 | 299.8 | 287.7 |
| Total | 92.8 | 77.4 | 421.8 | 406.4 |
| Share of recurring revenue, % | 32.9 | 35.3 | 28.9 | 29.2 |
| Business Innovation | ||||
| SEK million | 3 months | 3 months | 12 months | Full-year |
| May–Jul | May–Jul | Aug 2024 | May–Apr | |
| 2025 | 2024 | –Jul 2025 | 2024/2025 | |
| Recurring revenue | 5.4 | 5.8 | 22.8 | 23.2 |
| Of which cloud recurring revenue, CRR | 4.7 | 5.2 | 19.1 | 19.5 |
| Non-recurring revenue | 2.5 | 1.2 | 18.1 | 16.8 |
| Total | 7.9 | 7.0 | 40.9 | 40.0 |
| Share of recurring revenue, % | 68.4 | 82.9 | 55.7 | 58.0 |
| Other Operations | ||||
| SEK million | 3 months | 3 months | 12 months | Full-year |
| May–Jul | May–Jul | Aug 2024 | May–Apr | |
| 2025 | 2024 | –Jul 2025 | 2024/2025 | |
| Recurring revenue | 0.0 | 0.3 | 0.4 | 0.7 |
| Of which cloud recurring revenue, CRR | – | – | – | – |
| Non-recurring revenue | 0.0 | 0.2 | 0.0 | 0.0 |
| Total | 0.0 | 0.5 | 0.4 | 0.7 |
| Share of recurring revenue, % | 100.0 | 60.0 | 100.0 | 100.0 |

The Group applies the European Securities and Markets Authority (ESMA) Guidelines on Alternative Performance Measures. Alternative performance measures are applied since the company believes they provide valuable supplementary information for management and investors given that they play a central role when it comes to understanding and evaluating the Group's operations.
Shows the portion of external sales that is recurring. Recurring revenue refers to revenue from customers for the provision of a good or service during the term of a contract, wherein the customer cannot continue to benefit from the full functionality of the good or service without ongoing payments and the revenue stream is expected to recur for more than 12 months.
Recurring revenue mainly refers to revenue from subscription, support and maintenance agreements. The share delivered via the cloud is reported as cloud recurring revenue (CRR). Revenue from system implementations, migration and one-time purchases of licenses are not recognized as recurring revenue.
Recurring revenue divided by total external sales. Refer to Note 4.
| SEK thousand | 12 months Aug 2024 –Jul 2025 |
Full-year May–Apr 2024/2025 |
|---|---|---|
| Recurring revenue from customer contracts that have concluded or not been | ||
| renewed | 14,410 | 12,972 |
| Recurring revenue | 2,134,214 | 2,067,354 |
| Recurring revenue churn, % | 0.7 | 0.6 |
Indicates the share of recurring revenue from customer contracts that have concluded or not been renewed during the latest rolling 12-month period.
Recurring revenue from customer contracts that have concluded or not been renewed divided by total recurring revenue.
| Jul 31, 2025 |
Jul 31, 2024 |
Apr 30, 2025 |
|
|---|---|---|---|
| Equity, SEK thousand | 2,046,764 | 1,654,220 | 1,916,825 |
| Number of shares before and after dilution at | |||
| the end of the period | 192,667,489 | 192,667,489 | 192,667,489 |
| Equity per share before and after dilution, | |||
| SEK | 10.62 | 8.59 | 9.95 |
| Purpose | Calculation | ||
| Measures the company's net value per share and shows the change in shareholder capital per share over time. |
Equity divided by the number of shares before and after dilution at the end of the period. |
Non-interest-bearing liabilities and interest-bearing liabilities
| SEK thousand | Jul 31, | Jul 31, | Apr 30, |
|---|---|---|---|
| 2025 | 2024 | 2025 | |
| Non-interest-bearing liabilities | 1,602,181 | 1,471,828 | 1,740,213 |
| Interest-bearing liabilities | 108,924 | 45,884 | 99,190 |
| Total liabilities | 1,711,105 | 1,517,712 | 1,839,403 |
Indicates the proportion of the Company's liabilities with and without interest. Included in the calculation of the debt/equity ratio and capital employed.
Non-interest-bearing liabilities refers to liabilities without interest, such as accounts payable, advances from customers and tax liabilities. Interestbearing liabilities refers to liabilities with interest, such as lease liabilities.

| Purpose Shows the cash flow the company generated per share before |
Calculation Cash flow from operations divided by the number of shares before and |
|||
|---|---|---|---|---|
| dilution, SEK | 0.61 | -0.29 | 5.69 | 4.79 |
| Cash flow per share before and after | ||||
| at the end of the period | 192,667,489 | 192,667,489 | 192,667,489 | 192,667,489 |
| Number of shares before and after dilution | ||||
| Cash flow from operations, SEK thousand | 118,138 | -56,716 | 1,097,218 | 922,364 |
| 2025 | 2024 | –Jul 2025 | 2024/2025 | |
| 3 months May–Jul |
3 months May–Jul |
12 months Aug 2024 |
Full-year May–Apr |
capital investments and financing.
after dilution at the end of the period.
| Purpose | Calculation | ||
|---|---|---|---|
| Ratio of contracted order bookings to net sales | 2.86 | 2.69 | |
| Net sales | 3,281,829 | 3,239,811 | |
| Contracted order bookings | 9,400,633 | 8,706,063 | |
| Aug 2024 –Jul 2025 |
May–Apr 2024/2025 |
||
| SEK thousand | 12 months | Full-year |
Provides an indication of demand for the company's products and services.
Contracted order bookings divided by net sales.
| Liquidity | 1.9 | 1.7 | 1.7 |
|---|---|---|---|
| Current liabilities | 1,537,708 | 1,444,450 | 1,701,450 |
| Unutilized overdraft facilities | 15,000 | 15,000 | 15,000 |
| Current assets | 2,873,286 | 2,437,958 | 2,959,131 |
| SEK thousand | Jul 31, 2025 |
Jul 31, 2024 |
Apr 30, 2025 |
Shows the company's current ability to pay. Current assets plus unutilized overdraft facility divided by current liabilities.
Shows full-time positions in a certain period. Average number of full-time employees during the period.
| 3 months | 3 months | Full-year | |
|---|---|---|---|
| May–Jul | May–Jul | May–Apr | |
| 2025 | 2024 | 2024/2025 | |
| Nominal change, % | 5.8 | 24.0 | 9.3 |
| Exchange-rate effect, % | 6.3 | 0.7 | 0.9 |
| Change in unadjusted exchange rates, % | 12.1 | 24.7 | 10.2 |
Provides an indication of changes in financial measures for unadjusted exchange rates.
Amounts for the current year restated at last year's average exchange rates less last year's amounts at last year's average exchange rates, divided by last year's amounts at last year's rates.

| 3 months | 3 months | Full-year | |
|---|---|---|---|
| May–Jul | May–Jul | May–Apr | |
| 2025 | 2024 | 2024/2025 | |
| Nominal change, % | 19.0 | 44.0 | 39.6 |
| Exchange-rate effect, % | 16.9 | 1.8 | 1.9 |
| Change in unadjusted exchange rates, % | 35.9 | 45.8 | 41.5 |
Provides an indication of changes in financial measures for unadjusted exchange rates. Disclosures and adjustments of the effects of non-recurring transactions in operating profit and operating margin are made separately. When applicable, information about such transactions is provided on page 1.
Amounts for the current year restated at last year's average exchange rates less last year's amounts at last year's average exchange rates, divided by last year's amounts at last year's rates.
| 3 months | 3 months | Full-year | |
|---|---|---|---|
| May–Jul | May–Jul | May–Apr | |
| 2025 | 2024 | 2024/2025 | |
| Nominal change, % | 13.9 | 21.4 | 19.9 |
| Exchange-rate effect, % | 6.9 | 0.6 | 0.8 |
| Change in unadjusted exchange rates, % | 20.8 | 22.0 | 20.7 |
Provides an indication of changes in financial measures for unadjusted exchange rates.
Amounts for the current year restated at last year's average exchange rates less last year's amounts at last year's average exchange rates, divided by last year's amounts at last year's rates.
Purpose Calculation
Indicates future revenue in the company. The share of contracted order bookings that corresponds to what the customer has undertaken to purchase when the contract is entered into.
Indicates future revenue in the company. The value of orders received that corresponds to what the customer has procured and intends to purchase during the term of the contract.
| P/E ratio | ||
|---|---|---|
| SEK | 12 months | Full-year |
| Aug 2024 | May–Apr | |
| –Jul 2025 | 2024/2025 | |
| Share price at end of period | 363.0 | 296.60 |
| Earnings per share for the rolling 12-month period | 3.04 | 2.92 |
| P/E ratio, multiple | 119.4 | 101.6 |
Shows how the market values the company's profits and how long it may take for the shareholders to get a return on an investment in the share.
Share price at the end of the period divided by earnings per share for the most recent rolling 12-month period before dilution.

| 3 months May–Jul |
3 months May–Jul |
12 months Aug 2024 |
Full-year May–Apr |
|
|---|---|---|---|---|
| 2025 | 2024 | –Jul 2025 | 2024/2025 | |
| Profit for the period, SEK thousand | 102,785 | 80,401 | 585,754 | 563,371 |
| Average number of shares before and after dilution |
192,667,489 | 192,667,489 | 192,667,489 | 192,667,489 |
| Earnings per share before and after | ||||
| dilution, SEK | 0.53 | 0.42 | 3.04 | 2.92 |
| Purpose | Calculation | |||
| Shows each share's participation in the company's earnings during the reporting period. |
Profit/loss after tax divided by the average number of shares before or after dilution. This performance measure is defined in accordance with IFRS. |
| SEK thousand | 3 months | 3 months | 12 months | Full-year |
|---|---|---|---|---|
| May–Jul | May–Jul | Aug 2024 | May–Apr | |
| 2025 | 2024 | –Jul 2025 | 2024/2025 | |
| Profit for the period | 102,785 | 80,401 | 585,754 | 563,371 |
| Equity at start of period | 1,916,825 | 1,569,591 | 1,654,220 | 1,569,591 |
| Equity at end of period | 2,046,764 | 1,654,220 | 2,046,764 | 1,916,825 |
| Average equity | 1,981,795 | 1,611,906 | 1,850,492 | 1,743,208 |
| Return on equity, % | 5.2 | 5.0 | 31.7 | 32.3 |
Shows the return on capital attributable to the Parent Company owners.
| SFK thousand |
|---|
Shows profitability based on how much capital is used in the operations.
Profit after financial items plus financial expenses divided by average capital employed.
Profit for the period divided by average equity.
| SEK thousand | 3 months | 3 months | 12 months | Full-year |
|---|---|---|---|---|
| May–Jul | May–Jul | Aug 2024 | May–Apr | |
| 2025 | 2024 | –Jul 2025 | 2024/2025 | |
| Operating profit | 118,799 | 99,815 | 741,981 | 722,997 |
| Net sales | 765,854 | 723,836 | 3,281,829 | 3,239,811 |
| Operating margin, % | 15.5 | 13.8 | 22.6 | 22.3 |
Measures operational profitability. This measure is used for the purpose of management by objectives in the operations. Disclosures and adjustments of the effects of non-recurring transactions in operating profit and operating margin are made separately. When applicable, information about such transactions is provided on page 1.
Operating profit divided by net sales.

| 12 months | Full-year | |
|---|---|---|
| Aug 2024 | May–Apr | |
| –Jul 2025 | 2024/2025 | |
| Operating profit, SEK thousand | 741,981 | 722,997 |
| Number of shares before dilution | 192,667,489 | 192,667,489 |
| Operating profit per share, SEK | 3.85 | 3.75 |
Shows earnings per share before interest and taxes. Disclosures and adjustments of the effects of non-recurring transactions in operating profit are made separately. When applicable, information about such transactions is provided on page 1.
Operating profit divided by the number of shares before dilution on the balance-sheet date.
| SEK thousand | Jul 31, | Jul 31, | Apr 30, |
|---|---|---|---|
| 2025 | 2024 | 2025 | |
| Interest-bearing liabilities | 108,924 | 45,884 | 99,190 |
| Equity | 2,046,764 | 1,654,220 | 1,916,825 |
| Debt/equity ratio | 0.05 | 0.03 | 0.05 |
Shows to what extent the operations are financed by loans and describes the company's financial risk.
Interest-bearing liabilities divided by equity.
| SEK thousand | Jul 31, | Jul 31, | Apr 30, |
|---|---|---|---|
| 2025 | 2024 | 2025 | |
| Equity | 2,046,764 | 1,654,220 | 1,916,825 |
| Total assets | 3,757,869 | 3,171,932 | 3,756,229 |
| Equity/assets ratio, % | 54.5 | 52.2 | 51.0 |
Shows the portion of assets financed with equity. This measure is used for the purpose of management by objectives in the operations.
Equity divided by total assets on the balance-sheet date.
| SEK thousand | Jul 31, 2025 |
Jul 31, 2024 |
Apr 30, 2025 |
|---|---|---|---|
| Total assets | 3,757,869 | 3,171,932 | 3,756,229 |
| Non-interest-bearing liabilities | 1,602,181 | 1,471,828 | 1,740,213 |
| Capital employed | 2,155,688 | 1,700,104 | 2,016,016 |
Shows the portion of the company's assets that has been borrowed from, for example, the company's owners or external lenders, and shows the company's profitability in relation to externally financed capital and equity.
Total assets reduced by non-interest-bearing liabilities.

| SEK | 12 months | Full-year |
|---|---|---|
| Aug 2024 | May–Apr | |
| –Jul 2025 | 2024/2025 | |
| Operating profit per share before dilution | 3,851 | 3,752 |
| Operating profit per share before dilution five years earlier | 1,524 | 1,534 |
| Growth in operating profit per share before dilution | ||
| over a five-year period, % | 152.7 | 144.6 |
Shows the growth of the operations over a five-year period. This measure is used for the purpose of management by objectives in the operations. Disclosures and adjustments of the effects of nonrecurring transactions in operating profit and operating margin are made separately. When applicable, information about such transactions is provided on page 1.
| SEK thousand | 3 months May–Jul 2025 |
3 months May–Jul 2024 |
12 months Aug 2024 –Jul 2025 |
Full-year May–Apr 2024/2025 |
|---|---|---|---|---|
| Profit after financial items | 130,300 | 101,260 | 755,320 | 726,281 |
| Net sales | 765,854 | 723,836 | 3,281,829 | 3,239,811 |
| Profit margin, % | 17.0 | 14.0 | 23.0 | 22.4 |
Shows a comparison of profitability regardless of corporate tax rate.
Profit after financial items divided by net sales.
| 3 months | 3 months | 12 months | Full-year | |
|---|---|---|---|---|
| Jul 31, | Jul 31, | Jul 31, | Apr 30, | |
| 2025 | 2024 | 20253 | 20253 | |
| Contracted order bookings, SEK million | 1,309.5 | 615.0 | 9,400.6 | 8,706.1 |
| of which guaranteed order bookings, SEK million | 1,192.3 | 543.1 | 8,302.2 | 7,653.0 |
| Operating margin, % | 15.5 | 13.8 | 22.6 | 22.3 |
| Profit margin, % 3 | 17.0 | 14.0 | 23.0 | 22.4 |
| Average no. of employees | 1,328 | 1,222 | 1,275 | 1,249 |
| Cash flow per share, SEK 1, 2 | 0.61 | -0.29 | 5.69 | 4.79 |
| P/E ratio, multiple | n/a | n/a | 119.4 | 101.6 |
| Share price at end of period, SEK | 363.0 | 243.40 | 363.0 | 296.60 |
| Return on equity, % | 5.2 | 5.0 | 31.7 | 32.3 |
| Return on capital employed, % | 6.3 | 6.2 | 39.4 | 40.4 |
| Equity/assets ratio, % | 54.5 | 52.2 | 54.5 | 51.0 |
| Liquidity ratio, multiple | 1.9 | 1.7 | 1.9 | 1.7 |
| Equity per share, SEK 2 | 10.62 | 8.59 | 10.62 | 9.95 |
1 Cash flow from operations. 2 Before and after dilution. 3 The outcomes for R12 and full-year 2024/2025 include a positive effect from a patent settlement, a non-recurring transaction.

| SEK million | 2025/2026 | 2024/2025 | 2023/2024 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Q1 | Q4 | Q31 | Q2 | Q1 | Q4 | Q3 | Q2 | Q1 | |
| Net sales | 765.9 | 914.1 | 848.4 | 753.5 | 723.8 | 898.1 | 694.0 | 787.7 | 583.7 |
| Capitalized work for own use | 23.0 | 18.9 | 22.9 | 19.4 | 12.9 | 16.3 | 19.3 | 17.9 | 18.0 |
| Other operating income | 7.1 | 14.5 | 202.6 | 6.5 | 2.7 | 1.3 | 0.6 | 2.2 | 1.3 |
| Operating expenses | -649.6 | -719.8 | -729.9 | -642.5 | -613.5 | -687.0 | -614.9 | -607.5 | -509.2 |
| Depreciation/amortization and | |||||||||
| impairment | -27.6 | -28.8 | -29.3 | -27.3 | -26.1 | -31.3 | -24.7 | -23.6 | -24.5 |
| Operating profit | 118.8 | 198.9 | 314.7 | 109.6 | 99.8 | 197.4 | 74.4 | 176.7 | 69.3 |
| Total financial items | 11.5 | -16.9 | 17.8 | 0.9 | 1.5 | 14.7 | -1.5 | 13.6 | 8.2 |
| Profit after financial items | 130.3 | 182.0 | 332.5 | 110.5 | 101.3 | 212.1 | 72.9 | 190.3 | 77.5 |
| Tax on earnings for the period | -27.5 | -50.8 | -68.5 | -22.7 | -20.9 | -53.6 | -15.1 | -39.7 | -16.0 |
| Profit for the period | 102.8 | 131.2 | 264.0 | 87.8 | 80.4 | 158.5 | 57.8 | 150.6 | 61.6 |
1 The outcomes include positive effects from a patent settlement, a non-recurring transaction.
| 2025/2026 | 2024/2025 | 2023/2024 | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Q1 | Q4 | Q32 | Q2 | Q1 | Q4 | Q3 | Q2 | Q1 | |
| Contracted order bookings, SEK | |||||||||
| million | 1,309.5 2,900.3 | 967.6 4,223.1 | 615.0 | 896.9 1,853.6 | 503.0 2,970.0 | ||||
| of which guaranteed order | |||||||||
| bookings | 1,192.3 2,382.1 | 710.8 4,017.0 | 543.1 | 762.3 1,652.5 | 460.1 | 344.4 | |||
| Recurring revenue, SEK million | 549.2 | 574.6 | 525.8 | 484.7 | 482.3 | 463.5 | 434.7 | 429.6 | 397.2 |
| of which cloud services (CRR) | 179.4 | 184.1 | 162.8 | 121.3 | 122.8 | 113.8 | 103.2 | 93.4 | 86.4 |
| Operating margin, % | 15.5 | 21.8 | 37.1 | 14.5 | 13.8 | 22.0 | 10.7 | 22.4 | 11.9 |
| Earnings per share, SEK 1 | 0.53 | 0.68 | 1.37 | 0.46 | 0.42 | 0.82 | 0.30 | 0.78 | 0.32 |
| Cash flow per share, SEK 1 | 0.61 | 1.15 | 3.01 | 0.91 | -0.29 | 0.69 | 1.21 | 0.30 | -0.51 |
| Return on equity, % | 5.2 | 7.0 | 15.8 | 5.5 | 5.0 | 10.7 | 4.2 | 11.0 | 4.6 |
| Return on capital employed, % | 6.3 | 9.4 | 18.9 | 6.7 | 6.2 | 14.2 | 5.3 | 13.5 | 5.5 |
| Equity/assets ratio, % | 54.5 | 51.0 | 46.7 | 48.0 | 52.2 | 48.9 | 49.2 | 49.8 | 50.8 |
| Equity per share, SEK 1 | 10.62 | 9.95 | 9.40 | 7.95 | 8.59 | 8.15 | 7.20 | 6.96 | 7.20 |
| Share price at end of period, SEK | 363.0 | 296.6 | 254.0 | 283.0 | 243.4 | 219.2 | 195.1 | 120.6 | 168.6 |
1 Before and after dilution. 2 The outcomes include positive effects from a patent settlement, a non-recurring transaction.
| 2024/20252 | 2023/2024 | 2022/2023 | 2021/2022 | 2020/2021 | |
|---|---|---|---|---|---|
| Contracted order bookings, SEK million | 8,706.1 | 6,223.5 | 4,635.7 | 2,320.2 | 2,651.6 |
| Net sales, SEK million | 3,239.8 | 2,963.6 | 2,350.8 | 1,949.1 | 1,632.4 |
| Operating profit, SEK million | 723.0 | 517.8 | 455.7 | 383.4 | 350.1 |
| Profit after financial items, SEK million | 726.3 | 552.8 | 479.4 | 394.5 | 348.2 |
| Profit for the period, SEK million | 563.4 | 428.4 | 375.0 | 314.8 | 275.5 |
| Operating margin, % | 22.3 | 17.5 | 19.4 | 19.7 | 21.4 |
| Profit margin, % | 22.4 | 18.7 | 20.4 | 20.2 | 21.3 |
| Earnings per share before dilution, SEK 1 | 2.92 | 2.22 | 1.95 | 1.63 | 1.43 |
| Earnings per share after dilution, SEK 1 | 2.92 | 2.22 | 1.95 | 1.63 | 1.43 |
| Dividend/redemption program per share, SEK 1, 3 | 2.10 | 1.10 | 1.10 | 1.00 | 0.90 |
| Share price at end of year, SEK 1 | 296.60 | 219.20 | 161.70 | 124.80 | 121.00 |
| P/E ratio, multiple | 101.6 | 98.7 | 82.9 | 76.6 | 84.6 |
| Return on equity, % | 32.3 | 29.9 | 31.5 | 31.9 | 32.2 |
| Return on capital employed, % | 40.5 | 37.3 | 38.2 | 37.5 | 37.4 |
| Equity per share before dilution, SEK 1 | 9.95 | 8.15 | 6.73 | 5.61 | 4.65 |
| Equity per share after dilution, SEK 1 | 9.95 | 8.15 | 6.73 | 5.61 | 4.65 |
| Equity/assets ratio, % | 51.0 | 48.9 | 47.4 | 49.3 | 54.2 |
1 Comparative figures per share have been restated due to the 5:1 share split that Sectra carried out in the second quarter of 2021/2022. 2 The outcomes include positive effects from a patent settlement, a non-recurring transaction.
3 The amount for 2024/2025 pertains to the proposal to the AGM and includes an extraordinary dividend of SEK 1.00.

| Currency | Average rates in SEK | Closing rates in SEK | ||||
|---|---|---|---|---|---|---|
| 3 months | 3 months | |||||
| May–Jul | May–Jul | Δ % |
Jul 31, | Jul 31, | Δ | |
| 2025 | 2024 | 2025 | 2024 | % | ||
| US dollar, 1 USD | 9.54 | 10.63 | -10.3 | 9.73 | 10.69 | -9.0 |
| Euro, 1 EUR | 10.98 | 11.45 | -4.1 | 11.10 | 11.56 | -4.0 |
| British pound, 1 GBP | 12.89 | 13.54 | -4.8 | 12.89 | 13.73 | -6.1 |
A standard communication protocol used to capture, store and transfer medical images and related data.
A process for determining genetic material, DNA, in a sample.
The study of genetic material, meaning an organism's DNA. In medicine, a patient's genetic material is studied to increase understanding of the causes of disease. In cancer diseases, for example, a tumor's mutations are studied in DNA. The genetic information plays an important role in diagnosing cancer and customizing treatment, known as precision medicine.
The field of medicine dealing with the functions and diseases of the heart.
Basic infrastructure that is essential for the functioning of society, such as roads, bridges and electricity and water supply.
Equipment that uses mathematical manipulations (algorithms and keys) to encrypt information, so that it can be interpreted or read only by the intended recipient. To read encrypted information, the recipient must have the correct key and algorithm.
From the term cloud computing, meaning delivering services and sharing IT infrastructure over the internet.
A specialist medical area for the diagnosis and treatment of eye disorders.
A surgical specialty for disorders affecting the musculoskeletal system.
A specialized medical area that uses tissues and body fluids for diagnostic purposes.
Providing patient care that is highly adapted to individual conditions. Advanced diagnostic analyses are a cornerstone of precision medicine.
A health science discipline and medical specialty that uses technologies for imaging the human body, such as X-ray, magnetic resonance imaging (MRI) and ultrasound.
A subscription for Sectra's enterprise imaging solution. Under the new model, customers pay a more evenly distributed subscription fee every year instead of paying a higher license fee for software at the start of the contract and a lower rolling service fee. The fee is determined based on the functionality used and the number of different services utilized. When Sectra One is sold as fully cloud-based services, it is referred to as Sectra One Cloud.
Cryptographic methods and other measures designed to prevent unauthorized parties from accessing or influencing information in telecom and IT systems. The high assurance products that Sectra provides are approved by one or more nations and, for certain products, by the EU and NATO.

To contribute to a healthier and safer society.
To increase the effectiveness of healthcare, while maintaining or increasing the quality of care.
0 , To strengthen the stability and efficiency of society's most important functions through solutions for critical IT security.
Imaging IT Solutions helps hospitals across the world to become more efficient, enabling them to care for more patients and save more lives. Increased use of medical images and aging populations that are living longer pose huge challenges to healthcare. Sectra's IT solutions and services for medical diagnostic imaging enable greater efficiency and contribute to healthcare advancements. Sectra has exceeded 2,500 installations of medical IT systems, and customers include some of the largest healthcare providers in the world.
Secure Communications helps society's critical functions, government officials and diplomats to use modern technology to exchange information securely, thereby contributing to a stable and secure society. Sectra's solutions and services increase cybersecurity by protecting some of society's most sensitive information and communications. Several of the business area's products are approved by the EU, NATO, and national security authorities.
Business Innovation gathers smaller activities that could eventually lead to major growth in Sectra's main areas or related niches.
Customers and customer satisfaction are always assigned top priority to enable long-term growth. Close relationships with demanding customers ensure that Sectra's solutions meet market demands for quality, functionality and usability.
A corporate culture that motivates and inspires the company's employees to solve customer problems and constantly drive improvement. All so we can meet—and in many cases exceed—customer expectations.
Close cooperation with customers, universities and industrial partners in order to identify needs and ideas, combined with a corporate culture where management encourages the employees to test out new ideas and projects.
International expansion mainly in areas and regions where Sectra holds an established position. Expansion is primarily to be achieved through organic growth, in certain cases supplemented by acquisitions that strengthen the Group's organic growth.
For more information, visit https://investor.sectra.com

IT for healthcare and cybersecurity for critical social functions are rapidly changing markets that society needs to invest in. This creates major growth opportunities for companies such as Sectra.
Sectra has an over 45-year history of growth and profitability. Over 50% of the company's sales comprise recurring revenue from long-term customer contracts.
A strong corporate culture clearly focused on customer value and employees who are passionate about making a difference lead to satisfied customers. To safeguard our corporate culture, growth is primarily organic.
Sectra is an established brand in niche areas where trust and stable products are highly important success factors. We have a multinational reach, with thousands of customers worldwide.
By continuously investing in new and enhanced products and services, as well as how they are packaged and delivered, we create value for our customers. We also have a self-financed portfolio of research and business projects with the potential to add significant value in the future.
Contributing to healthier and safer societies is the foundation of Sectra's operations and business model. Helping our customers improve the efficiency and quality of patient care and increase cybersecurity in critical social functions is our most significant contribution to a sustainable society.
The principal owners, who have been part of the company since the 1980s, have firm dedication to the long-term development of the company, and all members of Group Management are shareholders.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.